Abstract |
The separate effects of alpha-hederin and thymoquinone, the two principal bioactive constituents of Nigella sativa, on four human cancer cell lines [A549 (lung carcinoma), HEp-2 (larynx epidermoid carcinoma), HT-29 ( colon adenocarcinoma) and MIA PaCa-2 (pancreas carcinoma)] were investigated. Alpha-hederin was also examined as a pro-drug. Each assessment quantified both cytotoxic and apoptotic/necrotic effects. Alpha-hederin and thymoquinone separately induced a dose- and time-dependent effect on the cell lines tested. HEp-2 cells were the most sensitive, exhibiting apoptosis with a higher incidence following thymoquinone treatment. Pre-treatment of cells with alpha-hederin, followed by thymoquinone or cisplatin, did not enhance the cytotoxicity or apoptosis induced by either drug. So, the membrane-perforating properties associated with saponins, here represented by alpha-hederin, enhance neither cytotoxicity nor apoptosis of these cancer cells.
|
Authors | Sara Rooney, M F Ryan |
Journal | Anticancer research
(Anticancer Res)
2005 May-Jun
Vol. 25
Issue 3B
Pg. 2199-204
ISSN: 0250-7005 [Print] Greece |
PMID | 16158964
(Publication Type: Journal Article)
|
Chemical References |
- Benzoquinones
- Drugs, Chinese Herbal
- Prodrugs
- Saponins
- beta-hederin
- Oleanolic Acid
- thymoquinone
|
Topics |
- Adenocarcinoma
(drug therapy)
- Apoptosis
(drug effects)
- Benzoquinones
(pharmacology)
- Cell Line, Tumor
- Colonic Neoplasms
(drug therapy)
- Dose-Response Relationship, Drug
- Drug Screening Assays, Antitumor
- Drugs, Chinese Herbal
(pharmacology)
- HT29 Cells
- Humans
- Inhibitory Concentration 50
- Laryngeal Neoplasms
(drug therapy)
- Lung Neoplasms
(drug therapy)
- Necrosis
- Neoplasms
(drug therapy)
- Nigella sativa
(chemistry)
- Oleanolic Acid
(analogs & derivatives, pharmacology)
- Pancreatic Neoplasms
(drug therapy)
- Prodrugs
(pharmacology)
- Saponins
(pharmacology)
|